»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (<9u-HF#
Zy/_
E@C}u
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 ZECfR>`x
<5051UEu
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© "y}5;9#,
1.Antigen presenting cell£¨APC£© bt?5*ETA
2.Activation induced cell death£¨AICD£© <hyKu
3.Chemokine a7opCmL
4.Major histocompatibility complex£¨MHC£© [
/r(__.
5.immunotolerance XCQs2CHt
RA 6w}:sq7
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© ?r4>" [
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ |G<|F`Cj
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà ;uGv:$([g
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ +}AI@+
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ 8oGRLYU N
5.±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌصã R=?[N
z
[-
w%/D%@
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© *-
X[u:
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ UiNP3TJ'L
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ {!`6zBsP
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ ]?4hyN
]:n,RO6
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ U<XG{<2
/-s6<e!
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 DmcZta8n]
eMzk3eOJ
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ pj(,Zd[47
1.Antigenic determinant q^nVN#
2.IgSF wd6owr
3.MBL;¾¶ iy"*5<;*DD
4.chemokine O6Y0XL
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ l
,).p
6.TCR-CD3¸´ºÏÎï ;*J
7.FADD£¨Fas-associated protein with death domain£© ,r}6iFu
8.AIDS AQ Ojit6p
9.Tumor rejection antigen 30{ gI0jk
10.AICD a q-~B~c`g
^zr`;cJ+c
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ i#O SC5ZI
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© A}!J$V:w]
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ EM_d8o)`B
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ Y-9I3?ar
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì (k P9hcV
/{2,zW
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ u?EN
zm#
?W
4Tc~b3\!Y
רҵ¿Î ÃâÒßѧ D+c>F5
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê 9M ]_nP Y
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell G
/W>S,(
5. Fc¦Å receptor 6. Cytokine >GuM]qn
¶þ¡¢ ÎÊ´ðÌâ $Kd>:f=A
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØɱÉË°Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 (?];VG
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ {h4E8.E
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁÜ°ÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ 5twhm
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâЩÌصãµÄÉúÎïѧÒâÒ壿 eH,or ,r
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦Óᣠ7Yy ;
cb bFw
r<\u6jF
0"#HJ
A44
T{'RV0%
1x^GWtRp
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ,,TnIouy
31)&vf[[
!9x}
רҵ¿Î ÃâÒßѧ -qoH,4w
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê X?Au/
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen \NC3'G:Ii
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin N g,j#
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test TC"<g
9. Hybridoma technic 10.Mitogen MQ4KdqgP
11.Dentritic cell 12.Immunoproliferation @ P|y{e6
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ xC?h2hIt
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨Äļ¸¸öÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ &{i{XcqH'
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦Óᣠ#;<Y[hR{P
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ hOeRd#AQK
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ < v
P=zk
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ snJ129}A
3a|\dav%
Wjc'*QCPl
##{taR8
[
3HfQ
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ j<x_ &1
A=4OWV?
*`U~?q}
רҵ¿Î ÃâÒßѧ 2?x4vI
np;
Ò»¡¢ Ãû´Ê½âÊÍ Xeajxcop#
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï F\!
`/4
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà Q20%"&Xp]
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ Y0>y8U
V
¶þ¡¢ ÎÊ´ðÌâ % `3jL7|
1¡¢ TÁÜ°Íϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ a
=QCp4^
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁÜ°Íϸ°ûºÍЧӦÎïÖÊ¡£ ceV}WN19l
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆ乲ͬÌص㼰ÓëÁÙ´²µÄ¹Øϵ¡£ MJvp6n
4¡¢ ºÎνÁÜ°Íϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ m2o0y++TjW
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØϵͳ£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ v1[29t<I!
Uv.)?YeGh
OCU
r{Nh
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ :>*7=q=
9my^
Y9B
2?5>o!C
רҵ¿Î ÃâÒßѧ
"#] $r
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê +H.`MZ=
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR >bxS3FCX
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA NgwbQ7)
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM H. c7Nle
¶þ¡¢ ÎÊ´ðÌâ Q@niNDaW2
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌص㡣 hc1N~$3!G
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ Gq6*SaTk
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖƵÄÒìͬµã¡£ <[phnU^
8
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆ书ÄÜ¡£ GmG5[?)
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ 9z0p5)]n>
|zU-KGO&
nNm`Hfi
<GJbmRc|
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ cR{#V1Z
5\v3;;A[
fox6)Uot
רҵ¿Î ÃâÒßѧ h 0|s
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê B1gR5p 0
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule LscGTs,
5. Autogous mixed lymphoyte reaction 9$Y=orpWxr
¶þ¡¢ ÎÊ´ðÌâ 5N]"~w*
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ KXrjqqXs
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ 1cDF!X]
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠ^pS~Z~[d/
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹Øϵ£¿ o4;(Zi#Z
|:o4w
<%^&2UMg
[ )F<V!
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ @CoIaUVP
2!\DPX
0]L"H<W
רҵ¿Î ÃâÒßѧ rOYx
b }1
RFGffA&
/1 dT+>
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê #Y!a6h+
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance 4| f*eO
5. Delayed type hypersensitivity ,6/V"kqIP
¶þ¡¢ ÎÊ´ðÌâ o-\[,}T)M
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ l{9Y
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ VTM/hJmwJ
3. ¼òÊöHLAÓëҽѧµÄ¹Øϵ¡£ [^
)g%|W
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠwkq 66
?
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷Óᣠks tIgcI
W^Yxn
y
.`lCWeHN
1oS/`)
u,
ff>/1
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ wJ]d&::@h
\bF{-" 7.
~&T~1xsFJ
רҵ¿Î ÃâÒßѧ s%S
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê Ri{=]
$
1. hypersensitivity 2. cluster of differentiation s1rCpzK0
3. adhesion molecules 4. supper antigen 5. split tolerance 1x)J[fyId
¶þ¡¢ ÎÊ´ðÌâ "[k3kAm
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ eavV?\uV%
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ g(052]
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ P?\6@_ Z
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ Ey2^?
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ I0-MRU~[K
:]KAkhFkbb
%A`+WYeuX
KHme&yMq
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 'NmRR]Q9
רҵ¿Î ÃâÒßѧ Pal=F0-Q\
Ò»¡¢ Ãû´Ê½âÊÍ =euni}7a
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å 29KiuP
5. GVHR 3n _htgcv
¶þ¡¢ ÎÊ´ðÌâ 5+vaE
2v
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óᣠs AkdMo
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌصãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ Psf#c:*_
)
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌص㡣 `3pW]&
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ m`XHKRp
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ ]Um/FA W
j%kncGS
XSR
4iu
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ LV Ge]
lD
tw;}jh
'L'R9&o<X
רҵ¿Î ÃâÒßѧ -RwE%cr
Ò»¡¢Ãû´Ê½âÊÍ :;}P*T*PU
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å W\3X=@|u)
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ G{}VPcrbC
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ fhiM U8(&
11. »ìºÏÁÜ°Íϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ ^q5#ihM
Èý¡¢ ÎÊ´ðÌâ [,Gg^*umS
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ +7Gwg
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ 4(
+PD&_J
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà _6Sp QW
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ oJ^P(] dw
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ @d'j zs
Q
,g\
{: /}NpA$
BGSw~6
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ P.cyO3l
J.a]K[ci
V3Bz
Mw\9r
רҵ¿Î ÃâÒßѧ i-1op> Y
Ò»¡¢Ãû´Ê½âÊÍ U^PgG|0N
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó '1[Ft03
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁÜ°Íϸ°ûµÄ±íÃæ±êÖ¾ vx
=&QavL
Èý¡¢ ÎÊ´ðÌâ )%TmAaj9d
1. ¼òÊöTÁÜ°Íϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ CIWO7bS
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ _`X:jj>
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ k$Vl fQ'+
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ 4g/dP^
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ q.vIc
?a
jXJyc'm7
G@0&
8
BT$_@%ea&
qq?!LEZ
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ 637:
oT_`O
Ò»¡¢Ãû´Ê½âÊÍ 'u658Tj
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï /Oono6j
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó +ZYn? #IQ
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ =4!mAo}
¶þ¡¢ ÎÊ´ðÌâ ooGM$U
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ {g6%(X\r.r
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ :UdF
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ M5B# TAybC
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ a*;b^Ze`v
/reX{Y
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ IV-{ve6
Ò»¡¢ Ãû´Ê½âÊÍ E`q_bn
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ 8L XHk l
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ 0(Ij%Wi,
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© J,G
lIv.A
10¡¢ ÒõÐÔÑ¡Ôñ mOSv9w#,
¶þ¡¢ ÎÊ´ðÌâ NA*#~
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 <{pz<io)
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ ijcm2FJcG
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 )[ ,A_3E
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ l%ZhA=TKQ
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. YqG7h,F
ToQ"Iy?
a?.=V
*I'yH8Fcn
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ %\DX#.
'S~5"6r
S'14hk<
רҵ¿Î ÃâÒßѧ *VeRVaBl
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ f)!Z~t &
1. Cytokines 2. adhesion molecules 3. graft versus host reaction P4?glh q#
4. immunologic tolerance 5. Opsonization -/k
3a*$/
Èý¡¢ ÎÊ´ðÌâ -&;TA0~;
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷ÓᣠG:JR7N$
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ U&xUfBDt
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ KG@8RtHsQ
4. ÃâÒßϵͳɱÉË°Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ G
j1_!.T
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ -+5>|N#
FqifriLN
+3`alHUK
]~%6JJN7
$|@ r!/W
Bf:Q2slqI
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ BD-AI
nd(S3rct&
o.\oA6P_
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ _wOt39e&
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ '!$%> ||S
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê 66 Tpi![
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ rH>)oThA#
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û SB7c.H,
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö -![|}pX
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð %bfZn9_m
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖƱ¸ÔÀí¡£ 8V(pugJ
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ <t,x RBk
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃ濹ԺͱíÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© 4 OX^(
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ p:%loDk
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ j.kG};f
go"Hf_
:Yks|VJ1
qw8Rlws%
03(4 x'z
6R5Qy]]E
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ V>
bCKtf&
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ >*n0n!vF
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ BUR*n;V`
]fD}
^s3G
Ò»¡¢ Ãû´Ê½âÊÍ _? OG1t!
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß +{UcspqM
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò -]=@s
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô L:8q8i
¶þ¡¢ÎÊ´ðÌâ c=+!>Z&i$G
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ 2|bn(QYz
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì H4JTGt1"
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì "Yca%:
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ B+0hzkPY
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ 4g7)i L^#~
l$'wD hN*